IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021-Reference-Cited by-同舟云学术

IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021

Published:2022-01 Issue: Volume:183 Page:109118
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Ogurtsova Katherine,Guariguata Leonor,Barengo Noël C.,Ruiz Paz Lopez-Doriga,Sacre Julian W.,Karuranga Suvi,Sun Hong,Boyko Edward J.,Magliano Dianna J.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Global estimates of undiagnosed diabetes in adults;Beagley;Diabetes Res Clin Pract,2014

2. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843.

3. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045;Cho;Diabetes Res Clin Pract,2018

4. Diabetes in the UK: 2019;Whicher;Diabet Med,2020

5. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort;Gedebjerg;J Diabetes Complications,2018

Cited by 402 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation, characterization, and in vitro inhibitory activity of a new alpha-glucosidase inhibitor from Schleichera oleosa (Lour.) Oken leaves;Journal of Pharmacy & Pharmacognosy Research;2025-01-01

2. Effect of intermolecular interactions and pharmacokinetic profile of antidiabetic agent (E)-N,N‑diethyl-2-(5(3‑hydroxy-4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl) acetamide;Chemical Physics Impact;2024-12

3. Factores determinantes de las hospitalizaciones evitables por diabetes tipo 2. Revisión narrativa;Atención Primaria;2024-11

4. Prevalence and determinants of diagnosed and undiagnosed diabetes in Hungary based on the nationally representative cross-sectional H-UNCOVER study;Diabetes Research and Clinical Practice;2024-10

5. Theaflavins mitigate diabetic symptoms in GK rats by modulating the INSR/PI3K-Akt/GSK-3 pathway and intestinal microbiota;International Journal of Biological Macromolecules;2024-10